Tag Archives: Durvalumab

Update: Merck KGaA, Pfizer score landmark FDA nod for checkpoint contender Avelumab

This is an update to my story: “German Merck, flying under Street’s radar, gets no respect; but not for long” Germany’s Merck KGaA and part­ner Pfizer Inc. came away with… Read more »

Drugs that may shape 2017 and the trends molding new-drug discovery

Here’s a look at the drugs that may shape 2017, compliments of FirstWord Pharma. It’s a list of some of the products I agree are likely to dominate industry news… Read more »

Drugs Targeting DNA Repair Mechanisms Inside Cells Show Promise in Fight Against Cancer

Drugs targeting DNA repair mechanisms inside cells are showing significant promise for a range of tumors and AstraZeneca PLC (London) believes it is well ahead of rivals in the emerging… Read more »